Cargando…
Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
Autores principales: | Meyer, Alain, Alsaleh, Ghada, Heuschling, Claude, Gottenberg, Jacques-Eric, Georgel, Philippe, Geny, Benard, Bahram, Seiamak, Sibilia, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133400/ https://www.ncbi.nlm.nih.gov/pubmed/27933205 http://dx.doi.org/10.1136/rmdopen-2016-000294 |
Ejemplares similares
-
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017) -
MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis
por: Ukichi, Taro, et al.
Publicado: (2019) -
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023) -
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study
por: Abe, Kazuya, et al.
Publicado: (2023) -
ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)